Clinical trial

Sipuleucel-T as Neoadjuvant Treatment in Prostate Cancer

NCT00715104

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2008-07-01

PhasePHASE2

Study timeline

Study start (unknown)2008-07-01Date precision: month

Registry last updated2015-05-04

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Prostate Cancerunresolved

Interventions

Sipuleucel-T with BoosterBIOLOGICAL

Sipuleucel-T without BoosterBIOLOGICAL

Sponsors & collaborators

Dendreonlead sponsor

University of California, San Franciscocollaborator

Mapped research locations

SeattleWashington, United States2 PortlandOregon, United States2 Los AngelesCalifornia, United States1 San FranciscoCalifornia, United States1 Salt Lake CityUtah, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00715104 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.